The newly approved Prodisc C Vivo, Prodisc C Nova and Prodisc C SK are all designed for cervical disc replacements, according to a July 13 company news release. They received the FDA’s pre-market application approval for single-level applications.
Prodisc C Vivo and Prodisc C Nova have been used outside the U.S. since 2009. Prodisc C Vivo is the most-used total disc replacement device outside the U.S.
The new approvals bring the devicemaker to four total cervical disc replacement devices with PMA approval.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
